About: Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 March 2006

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) bài báo khoa học (vi) наукова стаття, опублікована в березні 2006 (uk) im März 2006 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en marzu de 2006 (ast) scientific article published on 01 March 2006 (en) գիտական հոդված հրատարակված 2006 թվականի մարտի 1-ին (hy)
publication date	wds:Q56998541-004D4D04-3032-46FA-9E89-77AEB5272ED1
publication date	2006-03-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q56998541-6E0E8D80-21CC-43DD-8E05-ECFD8850A438
language of work or name	English
cites work	wds:Q56998541-02A56C21-6D6B-4B56-8B7B-1EDBEAC0DC51 wds:Q56998541-049273AF-809D-4ED4-91F6-765AB644A902 wds:Q56998541-109B1F62-0C44-4A6F-9254-AEB91696700D wds:Q56998541-16C6167D-87F8-460E-991B-9545AE86D156 wds:Q56998541-26C95BEA-7133-4C70-90CB-E364D623D88E wds:Q56998541-391C02ED-96E5-4AA0-A183-99F0C3EE448A wds:Q56998541-46D723B7-FECC-470C-8122-21A9DE186EC1 wds:Q56998541-4EFE70A8-5E20-43FE-9E2C-27404B87DF39 wds:Q56998541-59F01BC2-7A58-4AD2-8862-B2E44BA673FA wds:Q56998541-67CD96EE-45D3-4D17-A402-A95B156F6C83 wds:Q56998541-743FB188-31EE-4801-9C5E-B4252F5426C5 wds:Q56998541-765EB5D1-5669-4DFA-96C2-A8D4A6FCA3A0 wds:Q56998541-8A626931-0556-4149-9C6A-F58B8FEF0CB1 wds:Q56998541-A0ABA0EE-8BA3-4238-A84A-D5B27B06CCF1 wds:Q56998541-AAD28214-DB2F-4E91-9CF1-D55F267DBABC wds:Q56998541-CF2D739B-0588-45E9-9AD8-247AF87DDB47 wds:Q56998541-E46C9FD7-0681-4F07-B441-8BE0C1A0BD64 wds:Q56998541-E7D23C27-E612-4C93-81B1-5CB0F43681BE wds:Q56998541-EDCDBA11-B0D8-42DD-A9FD-63757A848BA6 wds:Q56998541-F7CEDB99-741E-43A0-B021-330D76998788 wds:Q56998541-F8E2AA06-AA57-4F25-B41D-2BE671360455
cites work	Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: a Scandinavian Sarcoma Group study High dose ifosfamide in combination with high dose methotrexate, adriamycin and cisplatin in the neoadjuvant treatment of extremity osteosarcoma: preliminary results of an Italian Sarcoma Group/Scandinavian Sarcoma Group pilot study Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli's 4th protocol. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders. Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin Changing pattern of pulmonary metastases with adjuvant chemotherapy in patients with osteosarcoma: results from the multiinstitutional osteosarcoma study A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup Prognostic significance of tumor volume in localized Ewing's sarcoma of bone in children and adolescents. Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup Histologic evaluation of necrosis in osteosarcoma induced by chemotherapy. Regional mapping of viable and nonviable tumor Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Rizzoli Experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarter Primary osteosarcoma in adults older than 40 years. Weekly high-dose methotrexate and doxorubicin for osteosarcoma: the Dana-Farber Cancer Institute/the Children's Hospital--study III A randomized study comparing high-dose methotrexate with moderate-dose methotrexate as components of adjuvant chemotherapy in childhood nonmetastatic osteosarcoma: a report from the Childrens Cancer Study Group Osteogenic sarcoma: alterations in the pattern of pulmonary metastases with adjuvant chemotherapy Pattern of relapse in patients with osteosarcoma of the extremities treated with neoadjuvant chemotherapy Chemotherapy in osteogenic sarcoma: the experience of the Pediatric Department of the Gustave Roussy Institute
author name string	wds:Q56998541-1D9841D1-EA45-4286-82B9-952A09A06F9E wds:Q56998541-74FD8DD2-C258-4996-B89F-97AC5AE7B4E2 wds:Q56998541-8F34F9CE-55F3-4D72-B7C5-4CC6D7F240E8 wds:Q56998541-BBDB36FC-C1B3-4871-BE5C-B4BE9B619C52
author name string	Mario Mercuri Gaetano Bacci Antonio Briccoli Michela Versari
rdfs:label	Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution (en) Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution (nl)
skos:prefLabel	Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution (en) Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution (nl)
name	Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution (en) Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution (nl)
author	wds:Q56998541-45881A72-3589-4F0E-9A5E-4D689C0C786E wds:Q56998541-FC6A0F1E-E3B2-4BD8-B106-E25A352C98FA
author	Piero Picci Alessandra Longhi
title	wds:Q56998541-16D999C1-0A6C-4457-B509-D31D7737460E
title	Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution (en)
page(s)	wds:Q56998541-BB10DC12-761C-417A-9BFD-A3E41EA74B42
page(s)	1154-1161
instance of	wds:Q56998541-A5E4672B-C7E9-4420-90C6-CA62CBA7E0B8
instance of	scholarly article
main subject	wds:Q56998541-3114C29D-8FC2-445C-833A-1449DB8CB846 wds:Q56998541-8F8F5F0E-5068-4A21-B9A9-F15FD973811A wds:Q56998541-C6E64302-6A47-46FF-A30A-1116641D9F4A
main subject	chemotherapy Patients neoadjuvant chemotherapy
PubMed ID	wds:Q56998541-8E9B000D-8102-4164-9FBA-EE81095C1803
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16421923
PubMed ID	16421923
published in	wds:Q56998541-7DFFF447-F36B-491C-9EC8-4BAC9A0F1F79
published in	Cancer
issue	wds:Q56998541-C9EA87BF-4AE6-4DE5-AA05-F7AF815DA0C7
volume	wds:Q56998541-61A342A9-7737-4EF0-8A3C-C907BD0E7737
issue	5
volume	106
DOI	wds:Q56998541-4E42660C-199B-47A0-B2CF-74B7E59B7345
DOI	http://dx.doi.org/10.1002/CNCR.21724
DOI	10.1002/CNCR.21724
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q56998541
is cites work of	Blocked autophagy by miR-101 enhances osteosarcoma cell chemosensitivity in vitro The biology of small leucine-rich proteoglycans in bone pathophysiology Prognostic significance of drug-regulated genes in high-grade osteosarcoma

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software